Advanced search
Publication Cover
Modern Rheumatology Case Reports Volume 4, 2020 - Issue 1
Journal homepage
336
Views
3
CrossRef citations to date
0
Altmetric
Case Reports

A case of granulomatous myositis in a patient with rheumatoid arthritis receiving anti-TNF-α treatment

Akito KawamuraDepartment of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan;
,
Yumi TsuchidaDepartment of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan; Correspondence[email protected]
,
Hirofumi ShodaDepartment of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan;
,
Kanae KuboDepartment of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan;
,
Naohiro UchioDepartment of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
,
Jun ShimizuDepartment of Neurology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan
&
Keishi FujioDepartment of Allergy and Rheumatology, Graduate School of Medicine, The University of Tokyo, Tokyo, Japan;
show all
Pages 1-5 | Received 08 Mar 2019, Accepted 03 Jun 2019, Published online: 24 Jun 2019

References

  • Radner H, Aletaha D. Anti-TNF in rheumatoid arthritis: an overview. Wien Med Wochenschr. 2015;165:3–9.
  • Zengin O, Onder ME, Alkan S, et al. Three cases of anti-TNF induced myositis and literature review. Rev Bras Reumatol Engl Ed. 2017;57:590–595.
  • Decock A, Van Assche G, Vermeire S, et al. Sarcoidosis-like lesions: another paradoxical reaction to anti-TNF therapy? J Crohns Colitis. 2017;11:378–383.
  • Daïen CI, Monnier A, Claudepierre P, et al. Sarcoid-like granulomatosis in patients treated with tumor necrosis factor blockers: 10 cases. Rheumatology (Oxford). 2009;48:883–886.
  • Wendling D, Nueffer JP. Muscular sarcoidosis under anti-TNF treatment in ankylosing spondylitis. Joint Bone Spine. 2018;85:769.
  • Prieto-González S, Grau JM. Diagnosis and classification of granulomatous myositis. Autoimmun Rev. 2014;13:372–374.
  • Hengstman GJ, De Bleecker JL, Feist E, et al. Open-label trial of anti-TNF-alpha in dermato- and polymyositis treated concomitantly with methotrexate. Eur Neurol. 2008;59:159–163.
  • Dastmalchi M, Grundtman C, Alexanderson H, et al. A high incidence of disease flares in an open pilot study of infliximab in patients with refractory inflammatory myopathies. Ann Rheum Dis. 2008;67:1670–1677.
  • Brunasso AM, Aberer W, Massone C. New onset of dermatomyositis/polymyositis during anti-TNF-α therapies: a systematic literature review. ScientificWorldJournal. 2014;2014:1.
  • Shijubo N, Yamaguchi T. Diagnosis criteria and classification of disease severity for sarcoidosis in Japan. Jpn J Sarcoid Other Granulomat Dis. 2015;35:3–8.
  • Takanashi T, Suzuki Y, Yoshino Y, et al. Granulomatous myositis: pathologic re-evaluation by immunohistochemical analysis of infiltrating mononuclear cells. J Neurol Sci. 1997;145:41–47.
  • Maurice MM, van der Graaff WL, Leow A, et al. Treatment with monoclonal anti-tumor necrosis factor alpha antibody results in an accumulation of Th1 CD4+ T cells in the peripheral blood of patients with rheumatoid arthritis. Arthritis Rheum. 1999;42:2166–2173.
  • Kawashima M, Miossec P. Effect of treatment of rheumatoid arthritis with infliximab on IFN gamma, IL4, T-bet, and GATA-3 expression: link with improvement of systemic inflammation and disease activity. Ann Rheum Dis. 2005;64:415–418.
  • Sakthivel P, Bruder D. Mechanism of granuloma formation in sarcoidosis. Curr Opin Hematol. 2017;24:59–65.
  • Aouizerate J, De Antonio M, Bassez G, et al. Myofiber HLA-DR expression is a distinctive biomarker for antisynthetase-associated myopathy. Acta Neuropathol Commun. 2014;2:154.
  • Ivaska L, Niemelä J, Lempainen J, et al. Aetiology of febrile pharyngitis in children: potential of myxovirus resistance protein A (MxA) as a biomarker of viral infection. J Infect. 2017;74:385–392.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.